Baxter International Inc.
BAX.SW
Get informed when a big investor buys or sells
+ FollowMarket Cap$12.14B
Close$
Share Statistics
| Market cap | $12.14 Billion |
|---|---|
| Enterprise Value | $19.66 Billion |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | -15.63% |
|---|---|
| Return on Assets | -4.90% |
| Return on Invested Capital | 2.56% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.71 |
| Enterprise Value to EBIT | 47.49 |
| Enterprise Value to Net Income | -21 |
| Total Debt to Enterprise | 0.49 |
| Debt to Equity | 1.56 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Baxter International Inc.
37,500 employees
CEO: Jose Almeida Baxter International Inc. is a global healthcare company that develops and supplies a broad spectrum of medical products and services through its various subsidiaries. The company's offerings encompass vital areas such as kidney care, in...